title: Oral antifungal drug interactions.
abstract: The recent approval of itraconazole and terbafine for the treatment of onychomycosis has launched a new era in the therapeutic management of this previously resistant form of dermatomycoses. These agents represent safe and effective treatments. The clinician should, however, become knowledgeable with the potential drug interactions that are discussed in this article.
authors.affiliation: Department of Dermatology, University of Minnesota, Minneapolis, USA.
authors.forename: H I
authors.initials: HI
authors.lastname: Katz
authors.forename: A K
authors.initials: AK
authors.lastname: Gupta
mesh_terms: D000284:Administration, Oral; D000935:Antifungal Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000494:pharmacology; D004347:Drug Interactions; D006801:Humans; D007408:Intestinal Absorption; D014009:Onychomycosis / Q000188:drug therapy*
chemical_list: D000935:Antifungal Agents